drugset / Trial / NCT02468830
Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder
NaSingle-groupOpen-labelTreatment
Summary
The objective is to evaluate the efficacy and safety of mirabegron to treat urinary incontinence in children with Overactive Bladder that are refractory and/or intolerant to antimuscarinics.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-01
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 25 mg | — |
| Subject | Mirabegron | Other / unclassified | 50 mg | — |